Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00622687
What this trial is testing

Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Charite University, Berlin, Germany 50
Post-approval studies (Phase 4)Ended earlyNCT00204763
What this trial is testing

Comparison of Esophageal and Anorectal Manometry Catheters

Who this might be right for
AchalasiaNutcracker EsophagusScleroderma+2 more
University of Utah 5
Very early researchLooking for participantsNCT07586267
What this trial is testing

CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Not applicableLooking for participantsNCT05273138
What this trial is testing

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
University Hospital, Lille 40
Not applicableUnknownNCT02795221
What this trial is testing

NVC Test in Order to Assess Pathological Changes in Family Members of Patient Diagnosed With SSc

Who this might be right for
According to the IRB Approval
Meir Medical Center 400
Not applicableUnknownNCT04515706
What this trial is testing

Iguratimod in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis, Diffuse
RenJi Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT01474122
What this trial is testing

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients

Who this might be right for
Digital Ulcers
Actelion 265
Large-scale testing (Phase 3)Study completedNCT01532869
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis

Who this might be right for
Sclerosis, Systemic
Hoffmann-La Roche 87
Large-scale testing (Phase 3)WithdrawnNCT00230373
What this trial is testing

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

Who this might be right for
Morphea
University of Alberta
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06888973
What this trial is testing

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisSystemic Lupus Erythematosus (SLE)Systemic Sclerosis+3 more
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 200
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Testing effectiveness (Phase 2)Study completedNCT00016458
What this trial is testing

Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT03198689
What this trial is testing

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Very early researchNot Yet RecruitingNCT07072884
What this trial is testing

GC012F in Patients With Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)
Qiong Fu 15
Large-scale testing (Phase 3)Study completedNCT02597933
What this trial is testing

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 580
Not applicableNot Yet RecruitingNCT07717060
What this trial is testing

Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis

Who this might be right for
Systemic SclerosisPulmonary Arterial HypertensionDigital Ulcers+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60
Post-approval studies (Phase 4)Looking for participantsNCT07112183
What this trial is testing

Open Label Treprostinil Raynaud's Study

Who this might be right for
Raynaud's DiseaseRaynaud PhenomenaRaynauds
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00781053
What this trial is testing

Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study

Who this might be right for
Skin Fibrosis
ISDIN 38
Not applicableEnrolling By InvitationNCT05859997
What this trial is testing

Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Bioray Laboratories 15
Not applicableNot Yet RecruitingNCT07175246
What this trial is testing

Exploring the Patterns of Sleep Disordered Breathing in Systemic Sclerosis Patients

Who this might be right for
Systemic SclerosisSleep-Disordered Breathing
Assiut University 30
Next Page